Check out what we have in store for you in the May Newsletter

Dear Advocaters,

In this edition of the HCV Advocate we have devoted nearly the entire issue to the 2018 International Liver Congress.  Lucinda Porter, RN and I cover some of our favorite posters and presentations in the current issue and in the upcoming June 2018 issue.

Lucinda’s Highlights from the 2018 International Liver Congress:

• Risk of Liver Fibrosis Progression in Patients with Undiagnosed Hepatitis C Virus Infection
• Protective Effect of Cannabis and Coffee Consumption on HCV-related Mortality in French HIV-HCV Co-Infected Patients
• Poor Awareness of Liver Disease Shortly Before Cirrhosis Death: Findings from a Large Community Cohort in the UK
• The Covert “C”; Prevalence: Risk Factors and Management of Hepatitis C in Psychiatric In-Patients
• Effectiveness of Hepatitis C Virus Screening Laws in the United States: Evidence from Paid Claims Data from 2010 to 2016
• Lower Risk of Multiple Sclerosis in Patients with Chronic Hepatitis
• Screening for Neurocognitive Dysfunction in Non-Cirrhotic Chronic Hepatitis C Infection in an Irish Academic Unit

Alan’s Highlights from the 2018 International Liver Congress:

• Testing and linkage to care outcomes in baby boomers versus young adults tested in the community and linked to care at a Federally Qualified Health Center in the US
• Linkage to HCV care and reincarceration following release from New York City jails
• Direct Antiviral Agents are safe and efficacious in pediatric patients with chronic hepatitis C; Real-world data from the public health perspective
• Salvage treatment of HCV patients by Sofosbuvir, Daclatasvir, Simeprevir, and Ribavirin after repeated treatment failures is associated with SVR and reduced risk of hepatocellular carcinoma

Hepatitis Headlines – read about a new hepatitis C therapy in clinical trials, hepatitis C screening rates among baby boomers, the opioid epidemic and about Hepatitis Awareness Month in May.

What’s Up!

We have updated the following HCSP’s Guide and Fact Sheets:

A Guide to Understanding HCV is our most popular downloaded publication. We have completely rewritten and designed the Guide.

HCSP Fact Sheets:

Overview of Disease Progression

HCV Disease Progression:  What is Fibrosis?

Don’t forget to check out PackHealth.com for a free resource to help patients navigate their HCV treatment journey.   Click on PackHealth.com/hcv and use promo code HCV2017.

Check out our Hep C Video of a patient journey through treatment and cure . . .

To Your Health,

Alan and the team of the HCV Advocate

Share This Page
Follow Us

Check out what we have in store for you in the April Newsletter

Dear Advocaters,

In this issue of the HCV Advocate newsletter we have SnapShots, new articles as well as a new feature called Hepatitis Headlines.  I hope you enjoy this new feature.

In this issue:

Hepatitis Research at CROI 2018 by Lucinda Porter, RN – The annual conference on Retroviruses and Opportunistic Infections (CROI) was recently held.  CROI is a gathering of top researchers from around the world who share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. Below are short summaries of some of the presentations pertinent to hepatitis C virus infection (HCV) that I found most interesting. Note that conference posters are preliminary investigations, and are not conclusive until the data are published in a peer-reviewed journal.
Read more …
Hepatitis Headlines – When hepatitis C makes the headlines, it is usually bad news. However, an article in Forbes had good news indeed. “The VA Will Eliminate Hepatitis C in Veterans by Year-End,” wrote John LaMattina on March 1, 2018.
Read more …
SnapShots  by Alan Franciscus

• The Adverse Effects of Interferon-Free Regimens in 149 816 Chronic Hepatitis C Treated Egyptian Patients—D. Attia, et. al.
• Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014—Jon E. Zibbell, PhD, et. al.
• Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies—J. Grebely, et. al.
  Read more …

HealthWise: Alcohol and Liver Transplantation by Lucinda Porter, RN – Imagine that you have a thirty-something year-old daughter or son. Your adult child is the parent of your grandchild, who is the love of your life. Tragedy has struck. Your adult child is a heavy drinker, and is now in the intensive care unit, fighting to live. Your child needs a liver transplant, and will die without one, leaving your grandchild minus a parent.
Read more …

What’s Up  We have reviewed or updated the following fact sheets:

• Injection Techniques Vein Care
• Water
• Nausea
• Diarrhea
• Maintaining a Positive Attitude

Don’t forget to check out PackHealth.com for a free resource to help patients navigate their HCV treatment journey.   Click on PackHealth.com/hcv and use promo code HCV2017

Check out our Hep C Video of a patient journey through treatment and cure . . .

To Your Health,

Alan and the team of the HCV Advocate

Share This Page
Follow Us